1: Jodrell DI, Bowman A, Rye R, Byrne B, Boddy A, Rafi I, Taylor GA, Johnston A, Clendeninn NJ. Related Articles, Links
A phase I study of the lipophilic thymidylate synthase inhibitor Thymitaq (nolatrexed dihydrochloride) given by 10-day oral administration.
Br J Cancer. 1999 Feb;79(5-6):915-20.
PMID: 10070890 [PubMed - indexed for MEDLINE]
2: O'Dwyer PJ, Laub PB, DeMaria D, Qian M, Reilly D, Giantonio B, Johnston AL, Wu EY, Bauman L, Clendeninn NJ, Gallo JM. Related Articles, Links
Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusion.
Clin Cancer Res. 1996 Oct;2(10):1685-92.
PMID: 9816117 [PubMed - indexed for MEDLINE]

Time used: 63 miliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005